Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Arsenic trioxide

EU orphan designation number: EU/3/16/1610   
Active ingredient: Arsenic trioxide
Indication: Treatment of acute myeloid leukaemia
Sponsor: Orsenix Holdings BV
Herengracht 468, 1017 CA Amsterdam, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/02/2016 Orphan designation EMA/OD/180/15 (2016)1103 of 17/02/2016